-
-
-
-
-
-
-
ANI Pharmaceuticals Highlights Significant Growth in 2025, Provides 2026 Financial Guidance, and Outlines Strategic Priorities
-
-
-
-
-
-
-
ANI Pharmaceuticals Announces NEW DAY Clinical Trial Results to be Presented in Late-Breaking Oral Presentation at the American Academy of Ophthalmology 2025 Meeting
-
-
-
-
-
-
-
ANI Pharmaceuticals Announces Presentation of Preclinical Data on the Use of Purified Cortrophin® Gel in an Experimental Autoimmune Uveitis (EAU) Mouse Model
-
-
-
-
-
-
-
ANI Pharma (ANIP) Announces FDA Approval of New Purified Cortrophin Gel Prefilled Syringe
-
-
-
-
-
-
-
ANI Pharma (ANIP) Announces the FDA Approval and Launch of Prucalopride Tablets with 180-Day CGT Exclusivity
-
-
-
-
-
-
-
Piper Sandler Starts ANI Pharmaceuticals (ANIP) at Overweight
-
-
-
-
-
-
-
ANI Pharma (ANIP) Launches Promethazine Hydrochloride and Dextromethorphan Hydrobromide Oral Solution
-
1,178,430 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

